{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:19:38Z","timestamp":1793715578901,"version":"4.6.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.04.098","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:18:40Z","timestamp":1716293920000},"page":"3883-3898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Design of a novel multiepitope vaccine with CTLA-4 extracellular domain against Mycoplasma pneumoniae: A vaccine-immunoinformatics approach"],"prefix":"10.1016","volume":"42","author":[{"given":"Xiaohong","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-1014","authenticated-orcid":false,"given":"Jiandong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.098_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10020119","article-title":"Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development","volume":"10","author":"Jiang","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2024.04.098_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00693","article-title":"Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae","volume":"7","author":"Yamazaki","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","article-title":"A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12519-023-00783-x","article-title":"Current status of Mycoplasma pneumoniae infection in China","volume":"20","author":"Yan","year":"2024","journal-title":"World J Pediatr"},{"key":"10.1016\/j.vaccine.2024.04.098_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-022-00556-z","article-title":"B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs","volume":"7","author":"Gavitt","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.098_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105463","article-title":"An attenuated multiple genetic mutant of Mycoplasma pneumoniae imparts good immuno-protection against M. pneumoniae pneumonia in BALB\/c mice","volume":"165","author":"Jiang","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2024.04.098_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18777-y","article-title":"Immunodominant proteins P1 and P40\/P90 from human pathogen Mycoplasma pneumoniae","volume":"11","author":"Vizarraga","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.04.098_b0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2741\/2093","article-title":"Adhesion proteins of Mycoplasma pneumoniae","volume":"12","author":"Chaudhry","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.vaccine.2024.04.098_b0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CVI.00283-07","article-title":"Cloning, expression, and immunological characterization of the P30 protein of Mycoplasma pneumoniae","volume":"15","author":"Varshney","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0050","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/IAI.00268-09","article-title":"Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development","volume":"77","author":"Schurwanz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.04.098_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103967","article-title":"Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein","volume":"124","author":"Rakib","year":"2020","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.vaccine.2024.04.098_b0060","doi-asserted-by":"crossref","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","article-title":"Designing of a Multi-epitope Vaccine against the Structural Proteins of Marburg Virus Exploiting the Immunoinformatics Approach","volume":"6","author":"Sami","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.vaccine.2024.04.098_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: From mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.290.5492.816","article-title":"Structure of murine CTLA-4 and its role in modulating T cell responsiveness","volume":"290","author":"Ostrov","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.098_b0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2024.04.098_b0080","first-page":"369","article-title":"Immunoadjuvant effect of the extracellular domain of canine CTLA-4 on the VP2 protein of canine parvovirus","volume":"48","author":"Wu","year":"2008","journal-title":"Wei Sheng Wu Xue Bao"},{"key":"10.1016\/j.vaccine.2024.04.098_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.599083","article-title":"Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy","volume":"11","author":"Kirtland","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.aller.2017.09.021","article-title":"Mycoplasma pneumoniae and toll-like receptors: A mutual avenue","volume":"46","author":"Naghib","year":"2018","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0095","article-title":"Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0100","article-title":"Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-\u03b1 Release Mediated by Mycoplasma pneumoniae","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0105","first-page":"1","article-title":"Toll-Like Receptor 4 Exacerbates Mycoplasma pneumoniaevia Promoting Transcription Factor EB-Mediated Autophagy","volume":"2022","author":"Liu","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.vaccine.2024.04.098_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104795","article-title":"Rational design of multimeric based subunit vaccine against Mycoplasma pneumonia: Subtractive proteomics with immunoinformatics framework","volume":"91","author":"Mahmood","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13721-021-00347-x","article-title":"In-silico design of a multi-epitope for developing sero-diagnosis detection of SARS-CoV-2 using spike glycoprotein and nucleocapsid antigens","volume":"10","author":"Javadi Mamaghani","year":"2021","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"10.1016\/j.vaccine.2024.04.098_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.806825","article-title":"Computational Design of a Multi-Epitope Vaccine Against","volume":"13","author":"Shaker","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621706","article-title":"Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target","volume":"12","author":"Sanches","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00726-006-0485-9","article-title":"Prediction of linear B-cell epitopes using amino acid pair antigenicity scale","volume":"33","author":"Chen","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.vaccine.2024.04.098_b0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2024.04.098_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092667","article-title":"In Silico Prediction of Cross-Reactive Epitopes of Tropomyosin from Shrimp and Other Arthropods Involved in Allergy","author":"Saetang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2024.04.098_b0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2105-7-131","article-title":"EpiJen: a server for multistep T cell epitope prediction","volume":"7","author":"Doytchinova","year":"2006","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2024.04.098_b0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: pan-specific MHC class I pathway epitope predictions","volume":"62","author":"Stranzl","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2024.04.098_b0155","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2024.04.098_b0165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.molimm.2019.09.013","article-title":"Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella","volume":"114","author":"Li","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2024.04.098_b0175","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1039\/D1RA06532G","article-title":"Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods","volume":"12","author":"Rafi","year":"2022","journal-title":"RSC Adv"},{"key":"10.1016\/j.vaccine.2024.04.098_b0180","article-title":"Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0185","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved protein structure prediction using predicted interresidue orientations","volume":"117","author":"Yang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.04.098_b0190","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2024.04.098_b0195","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: Protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0200","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10989-021-10327-4","article-title":"In Silico Methods for Secretory Production of a Fungal Hydrophobin (HYPAI) in Yeast to Serve as a Promising Target for Drug Delivery","volume":"28","author":"Darsaraei","year":"2021","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.vaccine.2024.04.098_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.724947","article-title":"LZerD Protein-Protein Docking Webserver Enhanced With Structure Prediction","volume":"8","author":"Christoffer","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.vaccine.2024.04.098_b0215","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.vaccine.2024.04.098_b0220","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2478\/jtim-2021-0038","article-title":"Repositioning of Fungal-based Peptides as Modulators of Angiotensin-converting Enzyme-related Carboxypeptidase, SARS-coronavirus HR2 Domain, and Coronavirus Disease 2019 Main Protease","volume":"9","author":"Oso","year":"2021","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.vaccine.2024.04.098_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151949","article-title":"Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus","volume":"225","author":"Ullah","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2024.04.098_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.994743","article-title":"Genetic engineering of baculovirus-insect cell system to improve protein production","volume":"10","author":"Hong","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0240","doi-asserted-by":"crossref","first-page":"e22252","DOI":"10.1096\/fj.202101538RR","article-title":"Immmunoinformatics-based design of a multi-epitope vaccine with CTLA-4 extracellular domain to combat Helicobacter pylori","volume":"36","author":"Ru","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2024.04.098_b0245","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12026-023-09374-4","article-title":"Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction\u2013based approaches","volume":"71","author":"Dey","year":"2023","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2024.04.098_b0250","article-title":"In Silico Design and Evaluation of PRAME+FliC\u0394D2D3 as a New Breast Cancer Vaccine Candidate","author":"Taheri-Anganeh","year":"2021","journal-title":"Iranian journal of medical sciences"},{"key":"10.1016\/j.vaccine.2024.04.098_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621706","article-title":"Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Using Transmembrane Proteins as a Target","volume":"12","author":"Sanches","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/md20030215","article-title":"In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis","volume":"20","author":"Pokharkar","year":"2022","journal-title":"Mar Drugs"},{"key":"10.1016\/j.vaccine.2024.04.098_b0265","doi-asserted-by":"crossref","first-page":"18103","DOI":"10.1039\/D1RA02885E","article-title":"Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2","volume":"11","author":"Obaidullah","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.vaccine.2024.04.098_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92176-1","article-title":"Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach","volume":"11","author":"Mahmud","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.098_b0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/07391102.2019.1571947","article-title":"Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease","volume":"38","author":"Shukla","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.vaccine.2024.04.098_b0280","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/pr10050895","article-title":"Production of Bivalent Subunit Vaccine for Porcine via 2A-Like Sequence in Baculovirus Expression Vector System","author":"Chen","year":"2022","journal-title":"Processes: MDPI AG"},{"key":"10.1016\/j.vaccine.2024.04.098_b0285","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268824000293","article-title":"<i>Mycoplasma pneumoniae<\/i>: current outbreak","volume":"152","author":"Wreghitt","year":"2024","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.04.098_b0290","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00129-2021","article-title":"Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies","author":"de Groot","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2024.04.098_b0295","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3390\/jcm11071782","article-title":"Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae","author":"Oishi","year":"2022","journal-title":"Journal of Clinical Medicine: MDPI AG"},{"key":"10.1016\/j.vaccine.2024.04.098_b0300","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biopha.2017.03.015","article-title":"Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4)","volume":"90","author":"Zhao","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2024.04.098_b0305","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-022-00495-z","article-title":"Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium","volume":"14","author":"Dey","year":"2022","journal-title":"Gut Pathogens"},{"key":"10.1016\/j.vaccine.2024.04.098_b0310","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41590-022-01289-w","article-title":"Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation","volume":"23","author":"Kennedy","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0315","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijbiomac.2020.07.117","article-title":"Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach","volume":"164","author":"Sanami","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2024.04.098_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09199-w","article-title":"Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection","volume":"7","author":"Ali","year":"2017","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T11:27:26Z","timestamp":1718018846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":64,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005681"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a novel multiepitope vaccine with CTLA-4 extracellular domain against Mycoplasma pneumoniae: A vaccine-immunoinformatics approach","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}